Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients

1. Muñoz-Culla, M.
2. Irizar, H.
3. Castillo-Triviño, T.
4. Sáenz-Cuesta, M.
5. Sepúlveda, L.
6. Lopetegi, I.
7. De Munain, A.L.
8. Olascoaga, J.
9. Baranzini, S.E.
10. Otaegui, D.